SE0202287D0 - New compounds - Google Patents

New compounds

Info

Publication number
SE0202287D0
SE0202287D0 SE0202287A SE0202287A SE0202287D0 SE 0202287 D0 SE0202287 D0 SE 0202287D0 SE 0202287 A SE0202287 A SE 0202287A SE 0202287 A SE0202287 A SE 0202287A SE 0202287 D0 SE0202287 D0 SE 0202287D0
Authority
SE
Sweden
Prior art keywords
compounds
new compounds
preparation
htreceptor
medicament
Prior art date
Application number
SE0202287A
Other languages
English (en)
Swedish (sv)
Inventor
Bjoern Nilsson
Original Assignee
Biovitrum Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Biovitrum Ab filed Critical Biovitrum Ab
Priority to SE0202287A priority Critical patent/SE0202287D0/xx
Publication of SE0202287D0 publication Critical patent/SE0202287D0/xx
Priority to DK03765414T priority patent/DK1534391T3/da
Priority to AU2003243101A priority patent/AU2003243101B2/en
Priority to CNB038195844A priority patent/CN1305871C/zh
Priority to AT03765414T priority patent/ATE353693T1/de
Priority to DE60311822T priority patent/DE60311822T2/de
Priority to KR1020057001012A priority patent/KR20050025628A/ko
Priority to JP2004522879A priority patent/JP4831966B2/ja
Priority to CA2492924A priority patent/CA2492924C/en
Priority to NZ537629A priority patent/NZ537629A/en
Priority to BR0312789-3A priority patent/BR0312789A/pt
Priority to SI200330754T priority patent/SI1534391T1/sl
Priority to EA200500235A priority patent/EA007539B1/ru
Priority to EP03765414A priority patent/EP1534391B1/en
Priority to PT03765414T priority patent/PT1534391E/pt
Priority to MXPA05000784A priority patent/MXPA05000784A/es
Priority to PCT/SE2003/001102 priority patent/WO2004009586A1/en
Priority to ES03765414T priority patent/ES2281666T3/es
Priority to MYPI20032688A priority patent/MY139613A/en
Priority to US10/622,055 priority patent/US7244722B2/en
Priority to TW092119594A priority patent/TW200404067A/zh
Priority to AR20030102607A priority patent/AR040605A1/es
Priority to IL16622605A priority patent/IL166226A0/xx
Priority to ZA200500205A priority patent/ZA200500205B/en
Priority to NO20050903A priority patent/NO20050903L/no
Priority to HK06100948A priority patent/HK1080859A1/xx

Links

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
SE0202287A 2002-07-19 2002-07-19 New compounds SE0202287D0 (sv)

Priority Applications (26)

Application Number Priority Date Filing Date Title
SE0202287A SE0202287D0 (sv) 2002-07-19 2002-07-19 New compounds
ES03765414T ES2281666T3 (es) 2002-07-19 2003-06-25 Novedosos derivados de piperazinil-pirazinona para el tratamiento de los desordenes relacionados con el receptor 5-ht2a.
EA200500235A EA007539B1 (ru) 2002-07-19 2003-06-25 Новые производные пиперазинона для лечения нарушений, связанных с 5-нт2а-рецептором
PT03765414T PT1534391E (pt) 2002-07-19 2003-06-25 Novos derivados e piperazinilo-pirazinona para o tratamento de desordens relacionadas com o receptor 5-ht
CNB038195844A CN1305871C (zh) 2002-07-19 2003-06-25 用于治疗与5－ht2a受体有关疾病的新哌嗪基－吡嗪酮衍生物
AT03765414T ATE353693T1 (de) 2002-07-19 2003-06-25 Neue piperazinyl-pyrazinon-derivate zur behandlung von 5-ht2a rezeptor-bedingten erkrankungen
DE60311822T DE60311822T2 (de) 2002-07-19 2003-06-25 Neue piperazinyl-pyrazinon-derivate zur behandlung von 5-ht2a rezeptor-bedingten erkrankungen
KR1020057001012A KR20050025628A (ko) 2002-07-19 2003-06-25 5-ｈｔ2ａ 수용체 관련 장애의 치료를 위한 신규피페라지닐-피라지논 유도체
JP2004522879A JP4831966B2 (ja) 2002-07-19 2003-06-25 ５−ｈｔ２ａ受容体関連疾患の治療のための新規ピペラジニル−ピラジノン誘導体
CA2492924A CA2492924C (en) 2002-07-19 2003-06-25 Novel piperazinone derivates for the treatment of 5-ht2a receptor-related disorders
NZ537629A NZ537629A (en) 2002-07-19 2003-06-25 Novel piperazinyl-pyrazinone derivatives for the treatment of 5-HT2A receptor-related disorders
BR0312789-3A BR0312789A (pt) 2002-07-19 2003-06-25 Novos derivados de piperazinil - pirazinona para o tratamento de distúrbios relacionados ao receptor 5-ht2a
SI200330754T SI1534391T1 (sl) 2002-07-19 2003-06-25 Novi piperazinil-pirazinonski derivati za zdravljenje motenj, povezanih z receptorjem 5-HT2A
DK03765414T DK1534391T3 (da) 2002-07-19 2003-06-25 Nye piperazinyl-pyrazinonderivater til behandling af 5-HT2A-recptor-relaterede forstyrrelser
EP03765414A EP1534391B1 (en) 2002-07-19 2003-06-25 Novel piperazinyl-pyrazinone derivatives for the treatment of 5-ht2a receptor-related disorders
AU2003243101A AU2003243101B2 (en) 2002-07-19 2003-06-25 Novel piperazinyl-pyrazinone derivatives for the treatment of 5-HT2A receptor-related disorders
MXPA05000784A MXPA05000784A (es) 2002-07-19 2003-06-25 Derivados de piperazinil-pirazinona novedosos para el tratamiento de los trastornos relacionados con el receptor 5-ht2a.
PCT/SE2003/001102 WO2004009586A1 (en) 2002-07-19 2003-06-25 Novel piperazinyl-pyrazinone derivatives for the treatment of 5-ht2a receptor-related disorders
TW092119594A TW200404067A (en) 2002-07-19 2003-07-17 New compounds
MYPI20032688A MY139613A (en) 2002-07-19 2003-07-17 Novel piperazinyl-pyrazinone derivatives for the treatment of 5-ht2a receptor-related disorders
US10/622,055 US7244722B2 (en) 2002-07-19 2003-07-17 Amino-substituted 1H-pyrazin-2-ones and 1H-quinoxalin-2-ones
AR20030102607A AR040605A1 (es) 2002-07-19 2003-07-18 Derivados de piperazinil-piperazinona para el tratamiento de desordenes relacionados con el receptor 5-ht2a
IL16622605A IL166226A0 (en) 2002-07-19 2005-01-10 Novel piperazinyl-pyrazinone derivatives for the treatment of 5-HT2A receptor-related disorders
ZA200500205A ZA200500205B (en) 2002-07-19 2005-01-10 Novel pierazinyl-pyrazinone derivatives for the treatment of 5-HT2A receptor-related disorders
NO20050903A NO20050903L (no) 2002-07-19 2005-02-18 Nye piperazinyl-pyrazinonderivater for behandling av 5HT-2A reseptorrelaterte forstyrrelser
HK06100948A HK1080859A1 (en) 2002-07-19 2006-01-20 Novel piperazinyl-pyrazinone derivatives for the treatment of 5-ht2a receptor-related disorders

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
SE0202287A SE0202287D0 (sv) 2002-07-19 2002-07-19 New compounds

Publications (1)

Publication Number Publication Date
SE0202287D0 true SE0202287D0 (sv) 2002-07-19

Family

ID=20288606

Family Applications (1)

Application Number Title Priority Date Filing Date
SE0202287A SE0202287D0 (sv) 2002-07-19 2002-07-19 New compounds

Country Status (5)

Country Link
JP (1) JP4831966B2 (xx)
EA (1) EA007539B1 (xx)
SE (1) SE0202287D0 (xx)
SI (1) SI1534391T1 (xx)
ZA (1) ZA200500205B (xx)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
RU2008129679A (ru) * 2005-12-21 2010-01-27 Янссен Фармацевтика Н.В. (Be) Новые замещенные пиразиноновые производные для применения при мсн-1-опосредованных заболеваниях

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FI193974A (xx) * 1973-07-13 1975-01-14 Merck & Co Inc
EG12387A (en) * 1975-04-21 1978-12-31 Merck & Co Inc Process for preparing of piperazinyl pyrazines
US4163849A (en) * 1978-03-17 1979-08-07 Merck & Co., Inc. Piperazinylpyrazines
ZA954689B (en) * 1994-06-08 1996-01-29 Lundbeck & Co As H 4-Aryl-1-(indanmethyl dihydrobenzofuranmethyl or dihydrobenzothiophenemethyl) piperidines tetrahydropyridines or piperazines
CN1242995C (zh) * 1999-05-21 2006-02-22 比奥维特罗姆股份公司 化合物,它们的用途和制备方法

Also Published As

Publication number Publication date
JP2005533847A (ja) 2005-11-10
ZA200500205B (en) 2006-07-26
EA007539B1 (ru) 2006-10-27
SI1534391T1 (sl) 2007-06-30
EA200500235A1 (ru) 2005-08-25
JP4831966B2 (ja) 2011-12-07

Similar Documents

Publication Publication Date Title
DK1519724T3 (da) Fredericamycin-derivater som lægemidler til behandling af tumorer
SE0200920D0 (sv) Novel compounds
SE0301700D0 (sv) Novel compounds
NO20070224L (no) 2-karbamid-4-fenyltiazolderivater, fremstilling og terapeutisk anvendelse derav
SE0001899D0 (sv) New compounds
BRPI0418251B8 (pt) fosfonatos, monofosfonamidatos, bisfosfonamidatos, e, composição farmacêutica os compreendendo
HK1084941A1 (en) Compounds and their use
NO20062335L (no) Nye diazaspiroalkaner og deres anvendelse i behandlingen av CCR8 medierte sykdommer
SE0401971D0 (sv) Piperidne derivatives
WO2005037798A3 (en) Amide or thiomide derivatives and their use in the treatment of pain
GB0112348D0 (en) Compounds
BRPI0412999A (pt) 2-aminotetralina substituìda para tratamento de depressão
SE0401345D0 (sv) Therapeutic compounds: Pyridine as scaffold
TW200731975A (en) Novel combinations of medicaments for the treatment of respiratory diseases
SE0401762D0 (sv) Novel compounds
SE0401342D0 (sv) Therapeutic compounds
SE0401970D0 (sv) Novel compounds
MY135850A (en) Ring-substituted diphenylazetidinones, process for their preparation, medicaments comprising these compounds and their use
TNSN04203A1 (en) Benzoxazinone-derived compounds, their preparation and use as medicaments
SE0302139D0 (sv) Novel compounds
MX2007007027A (es) Derivados piperazinilpiridina como agentes anti-obesidad.
DE602004008959D1 (de) Benzoäbüä1,4üdioxepinderivate
UA86776C2 (ru) Производные бензимидазола, фармацевтическая композиция, которая их содержит, способ их получения и применение
MY146802A (en) Novel drugs for treating respiratory diseases
TW200635595A (en) Medicaments for the treatment of prevention of fibrotic diseases